Sarepta Therapeutics (SRPT) Net Cash Flow (QoQ) (2010 - 2026)
Sarepta Therapeutics (SRPT) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278.97% |
| Dec 31, 2025 | 88.16% |
| Sep 30, 2025 | -62.92% |
| Jun 30, 2025 | 131.29% |
| Mar 31, 2025 | -195.25% |
| Dec 31, 2024 | 587.25% |
| Sep 30, 2024 | -325.41% |
| Jun 30, 2024 | -3,730.53% |
| Mar 31, 2024 | 99.03% |
| Dec 31, 2023 | 62.22% |
| Sep 30, 2023 | -1,469.85% |
| Jun 30, 2023 | 79.25% |
| Mar 31, 2023 | -32.38% |
| Dec 31, 2022 | -142.12% |
| Sep 30, 2022 | 147.85% |
| Jun 30, 2022 | 59.58% |
| Mar 31, 2022 | -270.48% |
| Dec 31, 2021 | 627.03% |
| Sep 30, 2021 | -145.56% |
| Jun 30, 2021 | 1,135.17% |